Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2003 by Johns Hopkins University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00244803
First received: October 25, 2005
Last updated: NA
Last verified: September 2003
History: No changes posted

October 25, 2005
October 25, 2005
January 2005
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.

This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites.

People who participated in FRAM 1 may join FRAM 2.

Observational
Observational Model: Defined Population
Time Perspective: Longitudinal
Not Provided
Not Provided
Not Provided
Not Provided
Human Immunodeficiency Virus
Not Provided
Not Provided
Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, Currier JS. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011 Aug;23(8):929-38. Epub 2011 Jun 24.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
101
Not Provided
Not Provided

Inclusion Criteria:18-65 years old, previous FRAM 1 participant, HIV positive -

Exclusion Criteria:Artificial knee or hip replacement or Harrington rod.Metal objects in the body.Pregnancy. Breastfeeding or less than 3 months after breastfeeding.Weight more than 300 pounds.On insulin, pancreatic enzymes, or thioridazine.

-

Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00244803
03-07-02-01
Not Provided
Not Provided
Johns Hopkins University
National Institutes of Health (NIH)
Principal Investigator: Joseph Cofrancesco Jr., M.D. Johns Hopkins University
Johns Hopkins University
September 2003

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP